PHS
INDV icon

PFM Health Sciences’s Indivior Pharmaceuticals INDV Stock Holding History

PFM Health Sciences’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.5M Sell
401,208
-173,458
-30% -$6.29M 1.41% 19
2026
Q1 		$17.5M Buy
574,666
+213,971
+59% +$7.07M 1.6% 19
2025
Q4 		$12.9M Sell
360,695
-200,831
-36% -$6.13M 1.29% 27
2025
Q3 		$13.5M Sell
561,526
-794,405
-59% -$16.6M 1.04% 33
2025
Q2 		$20M Buy
1,355,931
+196,098
+17% +$2.28M 1.7% 21
2025
Q1 		$11.1M Buy
+1,159,833
New +$12.2M 0.8% 31

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PFM Health Sciences's INDV Position: Q2 2026 in Review

PFM Health Sciences reduced its Indivior Pharmaceuticals (INDV) stake by 30% in Q2 2026, selling an estimated $6.29M and leaving 401,208 shares worth $16.5M. The position accounts for 1.41% of the portfolio, ranked #19.

PFM Health Sciences first reported a position in INDV in Q1 2025 and has held it in 6 quarters since. The position peaked at $20M in Q2 2025. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • PFM Health Sciences held 401,208 shares of Indivior Pharmaceuticals worth $16.5M as of Q2 2026.
  • PFM Health Sciences sold 173,458 Indivior Pharmaceuticals shares in Q2 2026, an estimated $6.29M.
  • Indivior Pharmaceuticals made up 1.41% of PFM Health Sciences's portfolio in Q2 2026, its #19 holding.
  • PFM Health Sciences first reported a position in Indivior Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • PFM Health Sciences's Indivior Pharmaceuticals position peaked at $20M in Q2 2025.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.